Testing a pentavalent vaccine in 2-month-old babies
Part of Brain & nervous system, Infections, Lungs & breathing clinical trials.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby has already received 4 doses of the same type of vaccine (DTaP-IPV/Hib pentavalent vaccine).
- You, as a parent or guardian, agree to the trial and sign a consent form.
- Your baby does not have a clotting or bleeding disorder diagnosed by a doctor.
- No other health issues that the study team thinks might make the trial unsuitable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new vaccine (LR20062) to see how well it protects healthy babies against several diseases. Your baby would receive the vaccine at their 2-month, 4-month, and 6-month checkups.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This study tests whether giving the inactivated polio vaccine (sIPV) at the same time as the DTaP or MMR vaccines is safe and works well in 2-month-old babies. It may help your baby get needed protection with fewer doctor visits.
This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
Hear when a new Pertussis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.